Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2950)
All Articles published online
|
Mar 10, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu BB, Wang WH. Survivin and pancreatic cancer. World J Clin Oncol 2011; 2(3): 164-168 [PMID: 21611091 DOI: 10.5306/wjco.v2.i3.164] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v2/i3/164.htm |
| Number | Citing Articles |
| 1 |
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
|
| 2 |
Wolfgang Glienke, Luise Maute, Johannes Wicht, Lothar Bergmann. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines. Tumor Biology 2012; 33(3): 757 doi: 10.1007/s13277-011-0290-2
|
| 3 |
DONG XU, QINGGUANG WANG, YONG AN, LIJIAN XU. miR-203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Molecular Medicine Reports 2013; 8(2): 379 doi: 10.3892/mmr.2013.1504
|
| 4 |
Jiang Chen, Xiao-Zhong Guo, Hong-Yu Li, Xu Liu, Li-Nan Ren, Di Wang, Jia-Jun Zhao. Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA. Vaccine 2013; 31(41): 4585 doi: 10.1016/j.vaccine.2013.07.055
|
| 5 |
Jayasree S. Nair, Elgilda Musi, Gary K. Schwartz. Selinexor (KPT-330) Induces Tumor Suppression through Nuclear Sequestration of IκB and Downregulation of Survivin. Clinical Cancer Research 2017; 23(15): 4301 doi: 10.1158/1078-0432.CCR-16-2632
|
| 6 |
Xiao-Peng Yang, Shang-Long Liu, Jian-Fei Xu, Shou-Gen Cao, Yu Li, Yan-Bing Zhou. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21. Experimental Cell Research 2017; 357(1): 79 doi: 10.1016/j.yexcr.2017.04.027
|
| 7 |
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa, Katerina Chlichlia. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Pharmacology & Therapeutics 2016; 165: 32 doi: 10.1016/j.pharmthera.2016.05.004
|
| 8 |
R. Ntagirabiri, S. Niyonkuru, R. Karayuba, G. Ndayisaba, G. Marerwa. Cancer du pancréas au Burundi, expérience du CHU de Kamenge. Journal Africain d'Hépato-Gastroentérologie 2012; 6(4): 312 doi: 10.1007/s12157-012-0422-3
|
| 9 |
Jaya Nigam, Abhijit Chandra, Hasan Raza Kazmi, Devendra Parmar, Devendra Singh, Vishal Gupta. Prognostic significance of survivin in resected gallbladder cancer. Journal of Surgical Research 2015; 194(1): 57 doi: 10.1016/j.jss.2014.07.054
|
| 10 |
George Mattheolabakis, Ioannis Papayannis, Jennifer Yang, Brandon M. Vaeth, Ruixue Wang, Jela Bandovic, Nengtai Ouyang, Basil Rigas, Gerardo G. Mackenzie. Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice. Cancer Prevention Research 2016; 9(7): 624 doi: 10.1158/1940-6207.CAPR-15-0344
|
| 11 |
BIN LIU, ZHEN WANG, HONG-YU LI, BO ZHANG, BO PING, YING-YI LI. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis. Oncology Reports 2014; 31(6): 2625 doi: 10.3892/or.2014.3158
|
| 12 |
David W. McIlwain, Melissa L. Fishel, Alexander Boos, Mark R. Kelley, Travis J. Jerde. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells. Oncotarget 2018; 9(13): 10962 doi: 10.18632/oncotarget.23493
|
| 13 |
Chao Qin, Qiang Cao, Pu Li, Xiaobing Ju, Meilin Wang, Jiawei Chen, Yilong Wu, Xiaoxin Meng, Jian Zhu, Zhengdong Zhang, Qiang Lu, Changjun Yin, Amanda Ewart Toland. Functional Promoter -31G>C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese Population. PLoS ONE 2012; 7(1): e28829 doi: 10.1371/journal.pone.0028829
|
| 14 |
Yasushi SHIBASAKI, Takanori SAKAGUCHI, Keisuke INABA, Shohachi SUZUKI, Satoshi BABA, Hiroyuki KONNO. Intraductal tubulopapillary neoplasm of the pancreas successfully treated with total pancreatectomy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2012; 73(8): 2061 doi: 10.3919/jjsa.73.2061
|
| 15 |
Seong Hwi Hong, Young Ju Lee, Eun Bi Jang, Hyun Ji Hwang, Eun Song Kim, Da Hyeon Son, Sung Yul Park, Hong Sang Moon, Young Eun Yoon. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC. International Journal of Molecular Sciences 2023; 25(1): 216 doi: 10.3390/ijms25010216
|
| 16 |
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Molecular Medicine Reports 2013; 7(3): 887 doi: 10.3892/mmr.2012.1247
|
| 17 |
Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao, Baoen Shan. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1498-z
|
| 18 |
Guangyu Ma, Boya Zhong, Shinya Okamoto, Yuanyuan Jiang, Kiyoko Kawamura, Hongdan Liu, Quanhai Li, Masato Shingyoji, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa. A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells. Tumor Biology 2015; 36(10): 8137 doi: 10.1007/s13277-015-3555-3
|
| 19 |
Sree Karani Kondapuram, Hema Kasthuri Ramachandran, Hemant Arya, Mohane Selvaraj Coumar. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development. Life Sciences 2023; 335: 122260 doi: 10.1016/j.lfs.2023.122260
|
| 20 |
SMIT SINGLA, JAMES A. PIPPIN, JEFFREY A. DREBIN. Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer. Oncology Reports 2012; 28(6): 2211 doi: 10.3892/or.2012.2053
|
| 21 |
Lina Song, Shuai Ren, Yali Yue, Ying Tian, Zhongqiu Wang. A Gold Nanocage Probe Targeting Survivin for the Diagnosis of Pancreatic Cancer. Pharmaceutics 2023; 15(5): 1547 doi: 10.3390/pharmaceutics15051547
|
| 22 |
Jie Wang, Ze Lu, Junfeng Wang, Minjian Cui, Bertrand Z. Yeung, David J. Cole, M. Guillaume Wientjes, Jessie L.-S. Au. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. Journal of Controlled Release 2015; 216: 103 doi: 10.1016/j.jconrel.2015.08.012
|
| 23 |
Eman Abdel Rahman Ismail, Hanan Mohamed Mahmoud, Lamis Mohamed Tawfik, Deena Mohamed Habashy, Amira Abdel Moneam Adly, Nayera Hazaa El‐Sherif, Mahmoud Ahmed Abdelwahab. BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis. European Journal of Haematology 2012; 88(2): 118 doi: 10.1111/j.1600-0609.2011.01734.x
|
| 24 |
Yumna H. Shabaik, Melissa Millard, Nouri Neamati, Aamir Ahmad. Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells. PLoS ONE 2013; 8(1): e54346 doi: 10.1371/journal.pone.0054346
|